Spirocyclic CAMs as novel and ultrapotent anti-HBV drugs (S-CAM)

Project Information

S-CAM

Grant agreement ID: 101138728

DOI

10.3030/101138728

Project closed

EC signature date 25 September 2023

Start date 1 October 2023

End date 31 March 2025

Funded under

• European Research Council (ERC)

Total cost

No data

EU contribution

€ 150 000,00

Coordinated by

OSPEDALE SAN RAFFAELE SRL
Italy

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (3)

The hidden strength of CD8+ T cells in chronic hepatitis B

Author(s): Francesco Andreata; Matteo Iannacone
Published in: Nature Immunology, 2024, ISSN 1529-2916
Publisher: Nature Immunology
DOI: 10.1038/S41590-024-01939-1

Therapeutic potential of co-signaling receptor modulation in hepatitis B

Author(s): Andreata, Francesco; Laura, Chiara; Ravà, Micol; Krueger, Caroline C; Ficht, Xenia; Kawashima, Keigo; Beccaria, Cristian G; Moalli, Federica; Partini, Bianca; Fumagalli, Valeria; Nosetto, Giulia; Di Lucia, Pietro; Montali, Ilaria; Garcia-Manteiga, José M; Bono, Elisa B; Giustini, Leonardo; Perucchini, Chiara; Venzin, Valentina; Ranucci, Serena; Inverso, Donato; De Giovanni, Marco; Genua, Marco; Ostuni, Renato; Lugli, Enrico; Isogawa, Masanori; Ferrari, Carlo; Boni, Carolina; Fisicaro, Paola; Guidotti, Luca G; Iannacone, Matteo
Published in: Cell, 2024, ISSN 1097-4172
Publisher: Cell
DOI: 10.1016/J.CELL.2024.05.038

Unlocking CD8+ T cell potential in chronic hepatitis B virus infection

Author(s): Fumagalli V.; Iannacone M.
Published in: Nature Reviews Gastroenterology & Hepatology, 2024, ISSN 1759-5053
Publisher: Nature Reviews Gastroenterology & Hepatology
DOI: 10.1038/S41575-024-01015-X